One study is a multinational adjuvant( post-operative) clinical trial evaluating disease-free and overall survival in women with breast cancer who take Femara after having remained disease-free with five years of tamoxifen therapy.

• 一项研究是多国辅药（后）床试验，用以评估乳癌患者服用弗隆后的无瘤生存率和整体生存率，这些女患者之前已进行了5年的他莫昔芬治疗，一直未发病。